Palladium-catalyzed sequential arylation and allylic alkylation of highly functionalized ketones: A concise synthesis of mesembrine

Organic Letters

Volumn 11, Issue 3, 2009, Pages 555-558

  Zhao, Yuanhong ^a   Zhou, Yongyun ^a   Liang, Leilei ^a   Yang, Xiaodong ^a   Du, Fengxiang ^a   Li, Ang ^a   Zhang, Hongbin ^a  

^a YUNNAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL PRODUCT; INDOLE ALKALOID; KETONE; MESEMBRINE; PALLADIUM;

ALKYLATION; ARTICLE; CATALYSIS; CHEMICAL STRUCTURE; CHEMISTRY; COMBINATORIAL CHEMISTRY; SYNTHESIS;

ALKYLATION; BIOLOGICAL PRODUCTS; CATALYSIS; COMBINATORIAL CHEMISTRY TECHNIQUES; INDOLE ALKALOIDS; KETONES; MOLECULAR STRUCTURE; PALLADIUM;

EID: 60849123945     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol802608r     Document Type: Article

References (45)

1. For recent reviews, see: (a) Kornienko, A.; Evidente, A. Chem. Rev. 2008, 108, 1982-2014.
2. (b) Somei, M.; Yamada, F. Nat. Prod. Rep. 2005, 22, 73-103.
3. (c) Jin, Z. Nat. Prod. Rep. 2005, 22, 111-126.
4. (d) Zezula, J.; Hudlicky, T. Synlett 2005, 388-405.
5. (e) Somei, M.; Yamada, F. Nat. Prod. Rep. 2004, 21, 278-311.
6. For recent reviews, see: (a) Trost, B. M.; Jiang, C. Synthesis 2006, 369-396.
7. (b) Christoffers, J.; Baro, A. Adv. Synth. Catal. 2005, 347, 1473-1482.
8. (c) Peterson, E. A.; Overman, L. E. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 11934-11948.
9. Douglas, C. J.; Overman, L. E. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 5363-5367.
10. Denissova, I.; Barriault, L. Tetrahedron 2003, 59, 10105-10146.
11. (a) Liao, X.; Wang, Z.; Hartwig, J. F. J. Am. Chem. Soc. 2008, 130, 195-200.
12. (b) Martin, R.; Buchwald, S. L. Angew. Chem., Int. Ed. 2007, 46, 7236-7239.
13. (c) Ackermann, L.; Spatz, J. H.; Gschrei, C. J.; Born, R.; Althammer, A. Angew. Chem., Int. Ed. 2006, 45, 7627-7630.
14. (d) Chen, G.; Kwong, F. Y.; Chan, H. O.; Yu, W.-Y.; Chan, A. S. C. Chem. Commun. 2006, 1413-1415.
15. (e) Churruca, F.; SanMartin, R.; Carril, M.; Tellitu, I.; Domínguez, E. Tetrahedron 2004, 60, 2393-2408.
16. (f) Nazaré, M.; Schneider, C.; Lindenschmidt, A.; Will, D. W. Angew. Chem., Int. Ed. 2004, 43, 4526-4528.
17. (g) Churruca, F.; SanMartin, R.; Tellitu, I.; Domínguez, E. Tetrahedron Lett. 2003, 44, 5925-5929.
18. (h) Culkin, D. A.; Hartwig, J. F. Acc. Chem. Res. 2003, 36, 234-245.
19. (i) Viciu, M. S.; Germaneau, R. F.; Nolan, S. P. Org. Lett. 2002, 4, 4053-4056.
20. (j) Sole, D.; Vallverdu, L.; Peidro, E.; Bonjoch, J. Chem. Commun. 2001, 1888-1889.
21. (k) Terao, Y.; Kametani, Y.; Wakui, H.; Satoh, T.; Miura, M.; Nomura, M. Tetrahedron 2001, 57, 5967-5974.
22. (l) Fox, J. M.; Huang, X.; Chieffi, A.; Buchwald, S. L. J. Am. Chem. Soc. 2000, 122, 1360-1370, and references cited therein.
23. (a) Iwama, T.; Rawal, V. H. Org. Lett. 2006, 8, 5725-5728.
24. (b) Chae, J.; Yun, J.; Buchwald, S. L. Org. Lett. 2004, 6, 4809.
25. (c) Hamada, T.; Chieffi, A.; Åhman, J.; Buchwald, S. L. J. Am. Chem. Soc. 2002, 124, 1261.
26. Ajamian, A.; Gleason, J. L. Angew. Chem., Int. Ed. 2004, 43, 3754-3760.
27. Regiospecific allylation of 3-alkoxy-2-cyclohexenone was first introduced by Stork and Danheiser, see: Stork, G.; Danheiser, R. L. J. Org. Chem. 1973, 38, 1775-1776.
28. Salvador, J. A. R.; Sá eMelo, M. L.; Neves, A. S. C. Tetrahedron Lett. 1997, 38, 119-122.
29. For bioactivities, isolation and structural determination of (-)-mesembrine, see: (a) Gericke, N. P.; Van Wyk, B. E. PCT Int. Appl. W09746234,1997; CAN 128: 80030.
30. (b) Jeffs, P. W.; Hawks, R. L.; Farrier, D. S. J. Am. Chem. Soc. 1969, 91, 3831-3839.
31. (c) Popelak, A.; Haack, E.; Lettenbauer, G.; Springier, H. Naturwissenschaften 1960, 47, 159.
32. For recent synthesis of mesembrine, see: (a) Roe, C.; Sandoe, E. J.; Stephenson, G. R.; Anson, C. E. Tetrahedron Lett. 2008, 49, 650-653.
33. (b) Tam, N. T.; Cho, C.-G. Org. Lett. 2007, 9, 3391-3392.
34. (c) Arns, S.; Lebrun, M.-E.; Grisé, C. M.; Denissova, I.; Barriault, L. J. Org. Chem. 2007, 72, 9314-9322.
35. (d) Paul, T.; Malachowski, W. P.; Lee, J. J. Org. Chem. 2007, 72, 930-937.
36. (e) Paul, T.; Malachowski, W. P.; Lee, J. Org. Lett. 2006, 8, 4007-4010.
37. (f) Taber, D. F.; He, Y. J. Org. Chem. 2005, 70, 7711-7714.
38. (g) Chavan, S. P.; Khobragade, D. A.; Pathak, A. B.; Kalkote, U. R. Tetrahedron Lett. 2004, 45, 5263-5265.
39. (h) Song, Z. L.; Wang, B. M.; Tu, Y. Q.; Fan, C. A.; zhang, S. Y. Org. Lett. 2003, 5, 2319-2321.
40. (i) Kulkarni, M. G.; Rasne, R. M.; Davawala, S. I.; Doke, A. K. Tetrahedron Lett. 2002, 43, 2297-2298.
41. (j) Taber, D. F.; Neubert, T. D. J. Org. Chem. 2001, 66, 143-147, and references cited therein.
42. Yu, W.; Mei, Y.; Kang, Y.; Hua, Z.; Jin, Z. Org. Lett. 2004, 6, 3217-3219.
43. (a) Hoshino, O.; Sawaki, S.; Shimamura, N.; Onodera, A.; Umezawa, B. Chem. Pharm. Bull. 1987, 35, 2734-2743.
44. (b) Hoshino, O.; Sawaki, S.; Shimamura, N.; Onodera, A.; Umezawa, B. Heterocycles 1978, 10, 61-66.
45. Takano, S.; Imamara, Y.; Ogasawara, K. Tetrahedron Lett. 1981, 22, 4479-4482.